FIRST REAL-WORLD HEMATOLOGIC ADVERSE EVENTS EXPERIENCE WITH NIRAPARIB IN ADVANCED OVARIAN CANCER

被引：0
|
作者：
Wang, Junjian [1 ]
Zhu, Jianqing [1 ]
机构：
[1] Univ Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2020年 / 30卷
关键词：
D O I：
10.1136/ijgc-2020-ESGO.134
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
418
引用
收藏
页码：A79 / A80
页数：2
相关论文
共 50 条
  • [31] Use of individualized starting dose and niraparib hematologic adverse event management costs in ovarian cancer
    Graybill, Whitney
    Vergote, Ignace
    Pothuri, Bhavana
    Anttila, Maarit
    O'Malley, David
    Lorusso, Domenica
    Haggerty, Ashley
    Fabbro, Michel
    Chan, John
    Heitz, Florian
    Willmott, Lyndsay
    Bruchim, Ilan
    Zhuo, Ying
    Estevez-Garcia, Purificacion
    Monk, Bradley
    Denys, Hannelore
    Knudsen, Anja
    Tinker, Anna
    Manso Sanchez, Luis
    Provencher, Diane
    Barretina-Ginesta, M. Pilar
    Hartman, John
    Booth, Donna
    Gonzalez-Martin, Antonio
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S274 - S275
  • [32] Use of individualized starting dose and niraparib hematologic adverse event management costs in ovarian cancer
    Graybill, Whitney S.
    Vergote, Ignace
    Pothuri, Bhavana
    Anttila, Maarit
    O'Malley, David M.
    Lorusso, Domenica
    Haggerty, Ashley F.
    Fabbro, Michel
    Chan, John K.
    Heitz, Florian
    Willmott, Lyndsay J.
    Bruchim, Ilan
    Zhuo, Ying
    Estevez-Garcia, Purificacion
    Monk, Bradley J.
    Denys, Hannelore
    Knudsen, Anja
    Tinker, Anna, V
    Sanchez, Luis Manso
    Provencher, Diane
    Barretina-Ginesta, Maria Pilar
    Hartman, John
    Booth, Donna, V
    Gonzalez-Martin, Antonio
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2025, 14 (01)
  • [33] Real world data of niraparib in platinum sensitive relapsed ovarian cancer: a multicenter experience of the MITO group
    Musacchio, Lucia
    Palluzzi, Eleonora
    Di Napoli, Marilena
    Lauria, Rossella
    Ferrandina, Gabriella
    Angioli, Roberto
    Bergamini, Alice
    Corrado, Giacomo
    Perniola, Giorgia
    Cassani, Chiara
    Savarese, Antonella
    Gori, Stefania
    De Angelis, Carmine
    Giannarelli, Diana
    Cinieri, Saverio
    Raspagliesi, Francesco
    Pignata, Sandro
    Lorusso, Domenica
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A360 - A361
  • [34] Real world data of niraparib in platinum sensitive relapsed ovarian cancer: A multicenter experience of the MITO group
    Musacchio, Lucia
    Palluzzi, Eleonora
    Di Napoli, Marilena
    Lauria, Rossella
    Ferrandina, Gabriella
    Angioli, Roberto
    Bergamini, Alice
    Corrado, Giacomo
    Perniola, Giorgia
    Cassani, Chiara
    Savarese, Antonella
    Gori, Stefania
    Greco, Filippo
    De Angelis, Carmine
    Zafarana, Elena
    Giannarelli, Diana
    Cinieri, Saverio
    Mosconi, Anna Maria
    Raspagliesi, Francesco
    Pignata, Sandro
    Scambia, Giovanni
    Lorusso, Domenica
    GYNECOLOGIC ONCOLOGY, 2024, 184 : 24 - 30
  • [35] Real-world clinical outcomes of patients with de novo advanced high-grade epithelial ovarian cancer eligible to niraparib maintenance in France
    Rodrigues, M.
    Joly, F.
    Ray-Coquard, I. L.
    Costaz, H.
    Classe, J-M.
    Floquet, A.
    Rouge, T. De la Motte
    Colombo, P-E.
    Gross, M. Provansal
    Leblanc, E.
    Pomel, C.
    Marchal, F.
    Barranger, E.
    Savoye, A. M.
    Guillemet, C.
    Petit, T.
    Pautier, P.
    Rouzier, R.
    Courtinard, C.
    Gladieff, L.
    ANNALS OF ONCOLOGY, 2021, 32 : S741 - S742
  • [36] Real-world experience of lenvatinib in patients with advanced anaplastic thyroid cancer
    Mijin Kim
    Jonghwa Ahn
    Dong Eun Song
    Jee Hee Yoon
    Ho-Cheol Kang
    Dong Jun Lim
    Won Gu Kim
    Tae Yong Kim
    Won Bae Kim
    Young Kee Shong
    Min Ji Jeon
    Bo Hyun Kim
    Endocrine, 2021, 71 : 427 - 433
  • [37] Real-world experience of lenvatinib in patients with advanced anaplastic thyroid cancer
    Kim, Mijin
    Ahn, Jonghwa
    Song, Dong Eun
    Yoon, Jee Hee
    Kang, Ho-Cheol
    Lim, Dong Jun
    Kim, Won Gu
    Kim, Tae Yong
    Kim, Won Bae
    Shong, Young Kee
    Jeon, Min Ji
    Kim, Bo Hyun
    ENDOCRINE, 2021, 71 (02) : 427 - 433
  • [38] Real-world experience with atezolizumab (atezo) in advanced urothelial cancer (UC).
    Barata, Pedro C.
    Gopalakrishnan, Dharmesh
    Elson, Paul
    Koshkin, Vadim S.
    Ornstein, Moshe Chaim
    Diaz-Montero, C. Marcela
    Haywood, Samuel
    Rayman, Patricia A.
    Finke, James
    Lamenza, Marcelo
    Devonshire, Sarah
    Profusek, Pam
    Allman, Kimberly D.
    Martin, Allison
    Beach, Jennifer
    Schach, Kim
    Gilligan, Timothy D.
    Rini, Brian I.
    Garcia, Jorge A.
    Grivas, Petros
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [39] A real-world experience of immune checkpoint inhibitors: immunotherapy related adverse events for locally advanced and metastatic non-small cell lung cancer
    Sidon, L.
    Dillon, M.
    Power, D.
    Dubash, S.
    LUNG CANCER, 2020, 139 : S49 - S49
  • [40] Real-world outcomes of niraparib treatment in patients with ovarian cancer: a multicenter non-interventional study in China
    Li, Jin
    Yang, Jianhua
    Shou, Huafeng
    Zhang, Lin
    Huang, Xiaohong
    Tang, Xuedong
    Zheng, Fei
    Liu, Fang
    Wen, Hao
    Yang, Huijuan
    Wang, Huaying
    Li, Ziting
    Chen, Xiaojun
    Ju, Xingzhu
    Cheng, Xi
    Tang, Jie
    Zhang, Meiqin
    Wu, Xiaohua
    CANCER COMMUNICATIONS, 2023, 43 (06) : 716 - 719
12345